65 related articles for article (PubMed ID: 3736171)
1. [Serum thyroglobulin in the follow-up of patients treated for differentiated carcinoma of the thyroid. Evaluation of factors determining its effectiveness].
García Solís D; Rodríguez Rodríguez JR; Acosta D; Astorga R
Med Clin (Barc); 1986 May; 86(18):748-52. PubMed ID: 3736171
[No Abstract] [Full Text] [Related]
2. Serum thyroglobulin measurements: clinical utility and technical limitations in the management of patients with differentiated thyroid carcinomas.
Spencer CA
Endocr Pract; 2000; 6(6):481-4. PubMed ID: 11155225
[No Abstract] [Full Text] [Related]
3. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
[TBL] [Abstract][Full Text] [Related]
4. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
[TBL] [Abstract][Full Text] [Related]
5. Serum thyroglobulin in differentiated thyroid carcinoma.
Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.
Hall FT; Beasley NJ; Eski SJ; Witterick IJ; Walfish PG; Freeman JL
Laryngoscope; 2003 Jan; 113(1):77-81. PubMed ID: 12514386
[TBL] [Abstract][Full Text] [Related]
7. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
8. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
Feldt-Rasmussen U; Hansen HS; Rasmusson B
Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
[No Abstract] [Full Text] [Related]
9. Value of serum thyroglobulin measurement in patients operating on for well differentiated thyroid carcinoma.
Rüter A; Smeds S; Lennquist S
Eur J Surg; 1998 Sep; 164(9):665-71. PubMed ID: 9728785
[TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
11. [Use of tumor markers in monitoring thyroid carcinoma].
Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
[TBL] [Abstract][Full Text] [Related]
12. Serum thyroglobulin measurement in various thyroidal disorders.
Osotimehin B; Hoffenberg R
Afr J Med Med Sci; 1980; 9(3-4):89-95. PubMed ID: 6283865
[TBL] [Abstract][Full Text] [Related]
13. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
14. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS
J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137
[TBL] [Abstract][Full Text] [Related]
15. [Value of the assay of thyroglobulin for postoperative surveillance of differentiated thyroid cancers].
Jaffiol C; Baldet L
Ann Med Interne (Paris); 1984; 135(5):359-64. PubMed ID: 6486615
[TBL] [Abstract][Full Text] [Related]
16. [Serum thyroglobulin (S-hTG): a tumor marker in patients with differentiated thyroid carcinoma (author's transl)].
Jänsch A; Heinze HG; Hast B
Strahlentherapie; 1981 Jun; 157(6):381-92. PubMed ID: 7256806
[No Abstract] [Full Text] [Related]
17. [Prospective analysis of criteria for interpreting measurements of thyroglobulin serum concentration during conditions of endogenous TSH stimulation in serum of patients with differentiated thyroid carcinoma].
Kukulska A; Gubała E; Turska M; Handkiewicz-Junak D; Czernik E; Deja R; Blamek S; Szpak S; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():332-8. PubMed ID: 12182045
[TBL] [Abstract][Full Text] [Related]
18. Serum thyroglobulin levels: their use in monitoring thyroid carcinoma.
Schwartz MA; Blahd WH
Conn Med; 1982 Apr; 46(4):189. PubMed ID: 7105708
[No Abstract] [Full Text] [Related]
19. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
Carmignani F; Piscopello L; Sammartini C
Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442
[TBL] [Abstract][Full Text] [Related]
20. [Assay of thyroglobulin in the study of patients with differentiated thyroid carcinoma].
Limbert E; Dinarés JM; Santos MA; Henriques MM
Acta Med Port; 1984 Mar; 5(3):73-8. PubMed ID: 6731030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
